In THA or TKA, risk for symptomatic VTE was higher with aspirin vs. enoxaparin at 90 d

Ann Intern Med. 2022 Dec;175(12):JC141. doi: 10.7326/J22-0096. Epub 2022 Dec 6.

Abstract

CRISTAL Study Group; Sidhu VS, Kelly TL, Pratt N, et al. Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial. JAMA. 2022;328:719-27. 35997730.

Publication types

  • Comment

MeSH terms

  • Anticoagulants
  • Arthroplasty, Replacement, Hip*
  • Arthroplasty, Replacement, Knee*
  • Aspirin
  • Enoxaparin
  • Humans
  • Randomized Controlled Trials as Topic
  • Venous Thromboembolism*

Substances

  • Anticoagulants
  • Aspirin
  • Enoxaparin